Aachen, Germany

Ulrike Bertram

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ulrike Bertram: Innovator in Pharmaceutical Formulations

Introduction

Ulrike Bertram, an esteemed inventor residing in Aachen, Germany, has made significant contributions to the field of pharmaceuticals. With a portfolio boasting five patents, she has focused her efforts on creating innovative formulations aimed at improving pain management, particularly in pediatric and adult patients.

Latest Patents

Among her latest inventions, Bertram has developed stable formulations for parenteral administration of Tapentadol, a medication used primarily for pain relief. One notable patent describes an aqueous pharmaceutical composition containing Tapentadol with a concentration ranging from 0.10 to 8.00 mg/mL. This formulation is specifically designed to achieve a buffered pH between 4.0 to 6.0, enhancing its stability and efficacy for treating acute pain in pediatric patients. In another patent, Bertram has formulated a composition wherein the concentration of Tapentadol exceeds 8.00 mg/mL, featuring a buffer system and a pH range of greater than 3.0 to less than 6.7, which caters to adult patients suffering from acute pain. Both inventions include a packaged kit and outline a process for preparation, showcasing her focus on practical applications in pain management.

Career Highlights

Ulrike Bertram has broadened her expertise through her tenure at Grünenthal GmbH, where she honed her skills in pharmaceutical development. Her contributions have been instrumental in advancing the company's product offerings in the realm of pain relief therapies, underscoring her impact on the pharmaceutical industry.

Collaborations

During her career, Bertram has collaborated with notable professionals such as Sebastian Schwier and Lutz Barnscheid. These partnerships demonstrate her ability to work collaboratively in a team environment, fostering innovation and pushing the boundaries of pharmaceutical research.

Conclusion

Ulrike Bertram's innovative spirit and commitment to enhancing pain management through her patented formulations make her a pivotal figure in the pharmaceutical landscape. Her work not only showcases her ingenuity but also holds significant promise for improving the quality of life for patients experiencing acute pain. As she continues her research and development efforts, the impact of her inventions will undoubtedly resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…